Literature DB >> 28381577

Understanding the Mechanism of the Broad-Spectrum Antiviral Activity of Favipiravir (T-705): Key Role of the F1 Motif of the Viral Polymerase.

Rana Abdelnabi1, Ana Theresa Silveira de Morais2, Pieter Leyssen1, Isabelle Imbert2, Stéphanie Beaucourt3, Hervé Blanc3, Mathy Froeyen4, Marco Vignuzzi3, Bruno Canard2, Johan Neyts5, Leen Delang1.   

Abstract

Favipiravir (T-705) is a broad-spectrum antiviral agent that has been approved in Japan for the treatment of influenza virus infections. T-705 also inhibits the replication of various RNA viruses, including chikungunya virus (CHIKV). We demonstrated earlier that the K291R mutation in the F1 motif of the RNA-dependent RNA polymerase (RdRp) of CHIKV is responsible for low-level resistance to T-705. Interestingly, this lysine is highly conserved in the RdRp of positive-sense single-stranded RNA (+ssRNA) viruses. To obtain insights into the unique broad-spectrum antiviral activity of T-705, we explored the role of this lysine using another +ssRNA virus, namely, coxsackievirus B3 (CVB3). Introduction of the corresponding K-to-R substitution in the CVB3 RdRp (K159R) resulted in a nonviable virus. Replication competence of the K159R variant was restored by spontaneous acquisition of an A239G substitution in the RdRp. A mutagenesis analysis at position K159 identified the K159M variant as the only other viable variant which had also acquired the A239G substitution. The K159 substitutions markedly decreased the processivity of the purified viral RdRp, which was restored by the introduction of the A239G mutation. The K159R A239G and K159M A239G variants proved, surprisingly, more susceptible than the wild-type virus to T-705 and exhibited lower fidelity in polymerase assays. Furthermore, the K159R A239G variant was found to be highly attenuated in mice. We thus demonstrate that the conserved lysine in the F1 motif of the RdRp of +ssRNA viruses is involved in the broad-spectrum antiviral activity of T-705 and that it is a key amino acid for the proper functioning of the enzyme.IMPORTANCE In this study, we report the key role of a highly conserved lysine residue of the viral polymerase in the broad-spectrum antiviral activity of favipiravir (T-705) against positive-sense single-stranded RNA viruses. Substitutions of this conserved lysine have a major negative impact on the functionality of the RdRp. Furthermore, we show that this lysine is involved in the fidelity of the RdRp and that the RdRp fidelity influences the sensitivity of the virus for the antiviral efficacy of T-705. Consequently, these results provide insights into the mechanism of the antiviral activity of T-705 and may lay the basis for the design of novel chemical scaffolds that may be endowed with a more potent broad-spectrum antiviral activity than that of T-705.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  CVB3; RdRp; favipiravir; fidelity; mutagenesis

Mesh:

Substances:

Year:  2017        PMID: 28381577      PMCID: PMC5446660          DOI: 10.1128/JVI.00487-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Poliovirus RNA-dependent RNA polymerase (3D(pol)). Assembly of stable, elongation-competent complexes by using a symmetrical primer-template substrate (sym/sub).

Authors:  J J Arnold; C E Cameron
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

2.  Mechanism of action of T-705 against influenza virus.

Authors:  Yousuke Furuta; Kazumi Takahashi; Masako Kuno-Maekawa; Hidehiro Sangawa; Sayuri Uehara; Kyo Kozaki; Nobuhiko Nomura; Hiroyuki Egawa; Kimiyasu Shiraki
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase.

Authors:  Jamie J Arnold; Marco Vignuzzi; Jeffrey K Stone; Raul Andino; Craig E Cameron
Journal:  J Biol Chem       Date:  2005-05-05       Impact factor: 5.157

4.  Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral.

Authors:  Leen Delang; Nidya Segura Guerrero; Ali Tas; Gilles Quérat; Boris Pastorino; Mathy Froeyen; Kai Dallmeier; Dirk Jochmans; Piet Herdewijn; Felio Bello; Eric J Snijder; Xavier de Lamballerie; Byron Martina; Johan Neyts; Martijn J van Hemert; Pieter Leyssen
Journal:  J Antimicrob Chemother       Date:  2014-06-20       Impact factor: 5.790

5.  The F1 motif of dengue virus polymerase NS5 is involved in promoter-dependent RNA synthesis.

Authors:  Nestor G Iglesias; Claudia V Filomatori; Andrea V Gamarnik
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

6.  Dose regimen of favipiravir for Ebola virus disease.

Authors:  France Mentré; Anne-Marie Taburet; Jeremie Guedj; Xavier Anglaret; Sakoba Keïta; Xavier de Lamballerie; Denis Malvy
Journal:  Lancet Infect Dis       Date:  2014-11-28       Impact factor: 25.071

7.  Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.

Authors:  Evelien Vanderlinden; Bram Vrancken; Jeroen Van Houdt; Vivek K Rajwanshi; Sarah Gillemot; Graciela Andrei; Philippe Lemey; Lieve Naesens
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

8.  Favipiravir elicits antiviral mutagenesis during virus replication in vivo.

Authors:  Armando Arias; Lucy Thorne; Ian Goodfellow
Journal:  Elife       Date:  2014-10-21       Impact factor: 8.140

9.  RNA-dependent RNA polymerase of Japanese encephalitis virus binds the initiator nucleotide GTP to form a mechanistically important pre-initiation state.

Authors:  Parag Surana; Vijaya Satchidanandam; Deepak T Nair
Journal:  Nucleic Acids Res       Date:  2013-11-28       Impact factor: 16.971

10.  Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir.

Authors:  Ana I de Ávila; Isabel Gallego; Maria Eugenia Soria; Josep Gregori; Josep Quer; Juan Ignacio Esteban; Charles M Rice; Esteban Domingo; Celia Perales
Journal:  PLoS One       Date:  2016-10-18       Impact factor: 3.240

View more
  27 in total

1.  Induced intra- and intermolecular template switching as a therapeutic mechanism against RNA viruses.

Authors:  Richard Janissen; Andrew Woodman; Djoshkun Shengjuler; Thomas Vallet; Kuo-Ming Lee; Louis Kuijpers; Ibrahim M Moustafa; Fiona Fitzgerald; Peng-Nien Huang; Angela L Perkins; Daniel A Harki; Jamie J Arnold; Belén Solano; Shin-Ru Shih; Marco Vignuzzi; Craig E Cameron; Nynke H Dekker
Journal:  Mol Cell       Date:  2021-10-22       Impact factor: 17.970

2.  The hepatitis C virus RNA-dependent RNA polymerase directs incoming nucleotides to its active site through magnesium-dependent dynamics within its F motif.

Authors:  Kaouther Ben Ouirane; Yves Boulard; Stéphane Bressanelli
Journal:  J Biol Chem       Date:  2019-03-13       Impact factor: 5.157

3.  Favipiravir Does Not Inhibit Chikungunya Virus Replication in Mosquito Cells and Aedes aegypti Mosquitoes.

Authors:  Sofie Jacobs; Lanjiao Wang; Ana Lucia Rosales Rosas; Ria Van Berwaer; Evelien Vanderlinden; Anna-Bella Failloux; Lieve Naesens; Leen Delang
Journal:  Microorganisms       Date:  2021-04-27

4.  Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs.

Authors:  Ujjwal Neogi; Kyle J Hill; Anoop T Ambikan; Xiao Heng; Thomas P Quinn; Siddappa N Byrareddy; Anders Sönnerborg; Stefan G Sarafianos; Kamal Singh
Journal:  Pathogens       Date:  2020-04-26

Review 5.  Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community.

Authors:  Zichao Luo; Melgious Jin Yan Ang; Siew Yin Chan; Zhigao Yi; Yi Yiing Goh; Shuangqian Yan; Jun Tao; Kai Liu; Xiaosong Li; Hongjie Zhang; Wei Huang; Xiaogang Liu
Journal:  Research (Wash D C)       Date:  2020-06-16

6.  Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis.

Authors:  Ashleigh Shannon; Barbara Selisko; Nhung-Thi-Tuyet Le; Johanna Huchting; Franck Touret; Géraldine Piorkowski; Véronique Fattorini; François Ferron; Etienne Decroly; Chris Meier; Bruno Coutard; Olve Peersen; Bruno Canard
Journal:  Nat Commun       Date:  2020-09-17       Impact factor: 14.919

7.  Propagation of respiratory viruses in human airway epithelia reveals persistent virus-specific signatures.

Authors:  Manel Essaidi-Laziosi; Francisco Brito; Sacha Benaoudia; Léna Royston; Valeria Cagno; Mélanie Fernandes-Rocha; Isabelle Piuz; Evgeny Zdobnov; Song Huang; Samuel Constant; Marc-Olivier Boldi; Laurent Kaiser; Caroline Tapparel
Journal:  J Allergy Clin Immunol       Date:  2017-08-08       Impact factor: 10.793

8.  Cyanorona-20: The first potent anti-SARS-CoV-2 agent.

Authors:  Amgad M Rabie
Journal:  Int Immunopharmacol       Date:  2021-05-29       Impact factor: 4.932

Review 9.  Structural and Functional Basis of the Fidelity of Nucleotide Selection by Flavivirus RNA-Dependent RNA Polymerases.

Authors:  Barbara Selisko; Nicolas Papageorgiou; François Ferron; Bruno Canard
Journal:  Viruses       Date:  2018-01-30       Impact factor: 5.048

10.  The mechanism of resistance to favipiravir in influenza.

Authors:  Daniel H Goldhill; Aartjan J W Te Velthuis; Robert A Fletcher; Pinky Langat; Maria Zambon; Angie Lackenby; Wendy S Barclay
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.